A new trading day began on Tuesday, with Olema Pharmaceuticals Inc (NASDAQ: OLMA) stock price up 9.09% from the previous day of trading, before settling in for the closing price of $8.91. OLMA’s price has ranged from $7.68 to $16.77 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Meanwhile, its annual earnings per share averaged -7.99%. With a float of $49.58 million, this company’s outstanding shares have now reached $54.99 million.
The firm has a total of 74 workers. Let’s measure their productivity. In terms of profitability, gross margin is 85.67%, operating margin of -7213.69%, and the pretax margin is -6511.62%.
Olema Pharmaceuticals Inc (OLMA) Breakdown of a Key Holders of the stock
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Olema Pharmaceuticals Inc is 13.47%, while institutional ownership is 94.07%. The most recent insider transaction that took place on Aug 01 ’24, was worth 35,796,000. In this transaction 10% Owner of this company sold 2,400,000 shares at a rate of $14.91, taking the stock ownership to the 783,118 shares. Before that another transaction happened on Jul 29 ’24, when Company’s Director sold 4,066 for $15.58, making the entire transaction worth $63,348. This insider now owns 752,217 shares in total.
Olema Pharmaceuticals Inc (OLMA) Recent Fiscal highlights
In its latest quarterly report, released on 9/30/2024, the company reported earnings of -0.49 per share, which was $0.1 lower than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months). Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.59 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -7.99% per share during the next fiscal year.
Olema Pharmaceuticals Inc (NASDAQ: OLMA) Trading Performance Indicators
Here are Olema Pharmaceuticals Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 7.10.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.19, a number that is poised to hit -0.65 in the next quarter and is forecasted to reach -2.61 in one year’s time.
Technical Analysis of Olema Pharmaceuticals Inc (OLMA)
Analysing the last 5-days average volume posted by the [Olema Pharmaceuticals Inc, OLMA], we can find that recorded value of 0.88 million was better than the volume posted last year of 0.74 million. As of the previous 9 days, the stock’s Stochastic %D was 30.28%. Additionally, its Average True Range was 0.89.
During the past 100 days, Olema Pharmaceuticals Inc’s (OLMA) raw stochastic average was set at 22.86%, which indicates a significant decrease from 37.98% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 103.47% in the past 14 days, which was higher than the 69.65% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $11.49, while its 200-day Moving Average is $11.88. Now, the first resistance to watch is $10.31. This is followed by the second major resistance level at $10.91. The third major resistance level sits at $11.82. If the price goes on to break the first support level at $8.80, it is likely to go to the next support level at $7.89. Now, if the price goes above the second support level, the third support stands at $7.29.
Olema Pharmaceuticals Inc (NASDAQ: OLMA) Key Stats
With a market capitalization of 556.93 million, the company has a total of 57,298K Shares Outstanding. Currently, annual sales are 0 K while annual income is -96,660 K. The company’s previous quarter sales were 0 K while its latest quarter income was -34,560 K.
